Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety, Efficacy, and Tolerance of Pico-Salax for Colon Cleansing Prior to Colonoscopy in an Elderly Population

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Lawrence Hookey, Queen's University
ClinicalTrials.gov Identifier:
NCT00906217
First received: May 19, 2009
Last updated: September 14, 2011
Last verified: September 2011
  Purpose

This study aims to further define the appropriate population for Pico-Salax, a purgative used prior to colonoscopy. Patients over the age of 70 years with normal renal function scheduled for colonoscopy will receive Pico-Salax and have pre and post preparation bloodwork and electrocardiograms (ECGs).


Condition
Colon Cleansing

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Safety, Efficacy, and Tolerance of Pico-Salax for Colon Cleansing Prior to Colonoscopy in an Elderly Population

Resource links provided by NLM:


Further study details as provided by Queen's University:

Primary Outcome Measures:
  • serum electrolyte changes pre and post preparation [ Time Frame: 2 months ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 50
Study Start Date: January 2009
Study Completion Date: September 2011
Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
elderly patients
patients older than 70 years with normal renal function

  Eligibility

Ages Eligible for Study:   70 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

patients older than 70 scheduled for colonoscopy

Criteria

Inclusion Criteria:

  • >70 years

Exclusion Criteria:

  • renal dysfunction
  • congestive heart failure
  • ileus
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00906217

Sponsors and Collaborators
Queen's University
Investigators
Principal Investigator: Lawrence Hookey, MD Queen's University
  More Information

No publications provided

Responsible Party: Lawrence Hookey, assistant professor of medicine, Queen's University
ClinicalTrials.gov Identifier: NCT00906217     History of Changes
Other Study ID Numbers: Hookey Picosalax Elderly Trial
Study First Received: May 19, 2009
Last Updated: September 14, 2011
Health Authority: Canada: Health Canada

Keywords provided by Queen's University:
colonoscopy
preparation
safety
elderly

ClinicalTrials.gov processed this record on November 20, 2014